Try our beta test site
4 studies found for:    neoplasms [CONDITION] AND (complementary alternative medicine) [ALL-FIELDS] | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
neoplasms [CONDITION] AND (complementary alternative medicine) [ALL-FIELDS] | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting The Influence of TaKeTiNa Music Therapy, Traditional Chinese Acupuncture and Clown Theatrical Performance on Quality of Life and the Therapeutic Process of Patients Undergoing Allogenic Stem Cell Transplantation
Conditions: Hematological Neoplasm;   Graft-Versus-Host Disease;   Depression;   Stem Cell Transplant Complications;   Quality of Life;   Leukemia
Interventions: Behavioral: Clown theatrical Performance;   Procedure: Acupuncture;   Behavioral: Music Therapy TaKeTiNa
2 Recruiting Vaccine Therapy With or Without Polysaccharide-K in Treating Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy
Conditions: HER2/Neu Positive;   Recurrent Breast Carcinoma;   Stage IV Breast Cancer
Interventions: Biological: HER-2/neu Intracellular Domain Protein;   Other: Laboratory Biomarker Analysis;   Biological: Pertuzumab;   Other: Placebo;   Biological: Polysaccharide-K;   Biological: Trastuzumab
3 Recruiting Acupuncture for Lymphedema Secondary to Breast Cancer Treatment
Condition: Lymphedema
Intervention: Device: Acupuncture + Electrical Stimulation
4 Recruiting Optimisation of Response for Organ Preservation in Rectal Cancer : Neoadjuvant Chemotherapy and Radiochemotherapy vs. Radiochemotherapy
Condition: Rectal Cancer
Interventions: Drug: Neoadjuvant chemotherapy Folfirinox, 4 cycles;   Radiation: 50 Gy, 2 Gy/session; 25 fractions;   Procedure: Local excision in good responders;   Procedure: Rectal excision in bad responders;   Drug: Capecitabine

Study has passed its completion date and status has not been verified in more than two years.